Cannabidiol oral solution
Cannabidiol oral solution is a pharmaceutical drug with 15 clinical trials. Currently 2 active trials ongoing. Historical success rate of 37.5%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
7
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
27.3%
3 of 11 finished
72.7%
8 ended early
2
trials recruiting
15
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis
SCORE Emerging Adult Cannabis Use & Stress
Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder
CBD for Sleep in People With HIV
Expanded Use of Cannabidiol Oral Solution
Clinical Trials (15)
Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis
SCORE Emerging Adult Cannabis Use & Stress
Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder
CBD for Sleep in People With HIV
Expanded Use of Cannabidiol Oral Solution
Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures
A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome
Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures
A Study to Assess Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms
Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy
Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms
Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder
Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome
Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome
Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders
All 15 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 15